Skip to main content

Table 3 Comparison of non-CP and CP group with average length of stay (ALOS)

From: Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation

Variable

Non-Clinical Pathway (n = 98)

Clinical Pathway (n = 95)

Pvalue

Average length of stay in days (LOS)

7.31 ± 2.75

5.83 ± 1.92

<0.001#

*Median LOS in days

7 (7–9)

5 (4–7)

<0.001ψ

  1. # = independent t test, *Median IQR (25th-75th), ψ = Mann Whitney U test, Significant level P <0.05.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us